Literature DB >> 17005713

Hepatic changes in the failing Fontan circulation.

Christoph H Kiesewetter1, Nick Sheron, Joseph J Vettukattill, Nigel Hacking, Brian Stedman, Harry Millward-Sadler, Marcus Haw, Richard Cope, Anthony P Salmon, Muthukumaran C Sivaprakasam, Tim Kendall, Barry R Keeton, John P Iredale, Gruschen R Veldtman.   

Abstract

BACKGROUND: The failing Fontan circulation is associated with hepatic impairment. The nature of this liver injury is poorly defined.
OBJECTIVE: To establish the gross and histological liver changes of patients with Fontan circulation relative to clinical, biochemical and haemodynamic findings.
METHODS: Patients were retrospectively assessed for extracardiac Fontan conversion between September 2003 and June 2005, according to an established clinical protocol. Twelve patients, mean age 24.6 (range 15.8-43.4) years were identified. The mean duration since the initial Fontan procedure was 14.1 (range 6.9-26.4) years.
RESULTS: Zonal enhancement of the liver (4/12) on CT was more common in patients with lower hepatic vein pressures (p = 0.007), and in those with absent cardiac cirrhosis on histological examination (p = 0.033). Gastro-oesophageal varices (4/12) were more common in patients with higher hepatic vein pressure (21 (6.3) vs 12.2 (2.2) mm Hg, p = 0.013) and associated with more advanced cirrhosis (p = 0.037). The extent of cirrhosis (7/12) was positively correlated with the hepatic vein pressure (r = 0.83, p = 0.003). A significant positive correlation was found between the Fontan duration and the degree of hepatic fibrosis (r = 0.75, p = 0.013), as well as presence of broad scars (r = 0.71, p = 0.021). Protein-losing enteropathy (5/12) occurred more frequently in patients with longer Fontan duration (11.7 (3.2) vs 17.9 (6.1) years, p = 0.038).
CONCLUSIONS: Liver injury, which can be extensive in this patient group, is related to Fontan duration and hepatic vein pressures. CT scan assists non-invasive assessment. Cardiac cirrhosis with the risk of developing gastro-oesophageal varices and regenerative liver nodules, a precursor to hepatocellular carcinoma, is common in this patient group.

Entities:  

Mesh:

Year:  2006        PMID: 17005713      PMCID: PMC1955554          DOI: 10.1136/hrt.2006.094516

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  29 in total

1.  Is liver fibrosis reversible?

Authors:  P A Bonis; S L Friedman; M M Kaplan
Journal:  N Engl J Med       Date:  2001-02-08       Impact factor: 91.245

2.  Large regenerative nodules in Budd-Chiari syndrome and other vascular disorders of the liver: CT and MR imaging findings with clinicopathologic correlation.

Authors:  Giuseppe Brancatelli; Michael P Federle; Luigi Grazioli; Rita Golfieri; Riccardo Lencioni
Journal:  AJR Am J Roentgenol       Date:  2002-04       Impact factor: 3.959

3.  Relation of mesenteric vascular resistance after Fontan operation and protein-losing enteropathy.

Authors:  Jack Rychik; Song Gui-Yang
Journal:  Am J Cardiol       Date:  2002-09-15       Impact factor: 2.778

4.  Sequelae after modified Fontan operation: postoperative haemodynamic data and organ function.

Authors:  R Kaulitz; I Luhmer; F Bergmann; B Rodeck; G Hausdorf
Journal:  Heart       Date:  1997-08       Impact factor: 5.994

5.  Juvenile hepatocellular carcinoma with congestive liver cirrhosis.

Authors:  Yuko Izumi; Naoki Hiramatsu; Ichiyo Itose; Takahiro Inoue; Akira Sasagawa; Satoshi Egawa; Tsutomu Nishida; Yoshimi Kakiuchi; Takashi Toyama; Fumihiko Nakanishi; Kazuyoshi Ohkawa; Kiyoshi Mochizuki; Tatsuya Kanto; Masahiko Tsujii; Tetsuo Takehara; Shingo Tsuji; Michio Kato; Akinori Kasahara; Norio Hayashi
Journal:  J Gastroenterol       Date:  2005-02       Impact factor: 7.527

6.  Mechanical stretch induces matrix metalloproteinase 1 production in human hepatic stellate cells.

Authors:  Takashi Goto; Ken-Ichiro Mikami; Kouich Miura; Shigetoshi Ohshima; Kazuo Yoneyama; Kunio Nakane; Daisuke Watanabe; Michiro Otaka; Sumio Watanabe
Journal:  Pathophysiology       Date:  2004-12

7.  Late systemic desaturation after total cavopulmonary shunt operations.

Authors:  O Stümper; J G Wright; M Sadiq; J V De Giovanni
Journal:  Br Heart J       Date:  1995-09

8.  Morphologic features of hepatic injury in cardiac disease and shock.

Authors:  J H Lefkowitch; L Mendez
Journal:  J Hepatol       Date:  1986       Impact factor: 25.083

9.  Specific sequelae after Fontan operation at mid- and long-term follow-up. Arrhythmia, liver dysfunction, and coagulation disorders.

Authors:  A H Cromme-Dijkhuis; J Hess; K Hählen; C M Henkens; M T Bink-Boelkens; A A Eygelaar; E Bos
Journal:  J Thorac Cardiovasc Surg       Date:  1993-12       Impact factor: 5.209

10.  Predicting outcome after cardiac surgery in patients with cirrhosis: a comparison of Child-Pugh and MELD scores.

Authors:  Amitabh Suman; David S Barnes; Nizar N Zein; Gavin N Levinthal; Jason T Connor; William D Carey
Journal:  Clin Gastroenterol Hepatol       Date:  2004-08       Impact factor: 11.382

View more
  75 in total

1.  Assessment of vascular remodeling after the Fontan procedure using a novel very high resolution ultrasound method: arterial wall thinning and venous thickening in late follow-up.

Authors:  Taisto Sarkola; Edgar Jaeggi; Cameron Slorach; Wei Hui; Timothy Bradley; Andrew N Redington
Journal:  Heart Vessels       Date:  2012-02-14       Impact factor: 2.037

2.  Hemodynamic phenotype of the failing Fontan in an adult population.

Authors:  Camden L Hebson; Nancy M McCabe; Robert W Elder; William T Mahle; Michael McConnell; Brian E Kogon; Emir Veledar; Maan Jokhadar; Robert N Vincent; Anurag Sahu; Wendy M Book
Journal:  Am J Cardiol       Date:  2013-09-25       Impact factor: 2.778

3.  Risk Factors for an Elevated Ventricular End-Diastolic Pressure Prior to the Fontan Operation.

Authors:  Matthew C Schwartz; Michael A Brock; David Nykanen; William DeCampli
Journal:  Pediatr Cardiol       Date:  2017-11-27       Impact factor: 1.655

Review 4.  Choosing the best contraceptive method for the adult with congenital heart disease.

Authors:  Candice K Silversides; Mathew Sermer; Samuel C Siu
Journal:  Curr Cardiol Rep       Date:  2009-07       Impact factor: 2.931

5.  Hepatic Changes in the Fontan Circulation: Identification of Liver Dysfunction and an Attempt to Streamline Follow-up Screening.

Authors:  T Ackerman; A Geerts; H Van Vlierberghe; J De Backer; K François
Journal:  Pediatr Cardiol       Date:  2018-07-21       Impact factor: 1.655

6.  Risk factors and serological markers of liver cirrhosis after Fontan procedure.

Authors:  Mikiko Shimizu; Kenji Miyamoto; Yunosuke Nishihara; Gaku Izumi; Shuji Sakai; Kei Inai; Toshio Nishikawa; Toshio Nakanishi
Journal:  Heart Vessels       Date:  2015-09-19       Impact factor: 2.037

7.  Transvenous hepatic biopsy in stable Fontan patients undergoing cardiac catheterization.

Authors:  William N Evans; Brody J Winn; Noel S Yumiaco; Alvaro Galindo; Abraham Rothman; Ruben J Acherman; Humberto Restrepo
Journal:  Pediatr Cardiol       Date:  2014-05-10       Impact factor: 1.655

8.  Effect of Fontan operation on liver stiffness in children with single ventricle physiology.

Authors:  Frank W DiPaola; Kurt R Schumacher; Caren S Goldberg; Joshua Friedland-Little; Aishwarya Parameswaran; Jonathan R Dillman
Journal:  Eur Radiol       Date:  2016-10-17       Impact factor: 5.315

9.  The Fontan pathway: What's down the road?

Authors:  Sachin Khambadkone
Journal:  Ann Pediatr Cardiol       Date:  2008-07

10.  Congenital Heart Defects in Adults : A Field Guide for Cardiologists.

Authors:  Anitra Romfh; Francesca Romana Pluchinotta; Prashob Porayette; Anne Marie Valente; Stephen P Sanders
Journal:  J Clin Exp Cardiolog       Date:  2012-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.